Nationwide Recall of Specific Xanax Bottles: What Patients Need to Know
A voluntary nationwide recall has been issued for specific bottles of Xanax, a widely prescribed medication used to treat anxiety and panic disorders. The recall, initiated by pharmaceutical company Viatris Inc., affects a particular lot of extended-release tablets that failed to meet critical quality standards.
- Product: Xanax (alprazolam) 3mg extended-release tablets.
- Affected Lot: 8177156.
- Reason: Failure to meet dissolution specifications.
- Risk: Potential for incorrect dosage or reduced effectiveness.
Why Was Xanax Recalled?
The recall was triggered as one lot of the medication failed to meet “dissolution specifications.” In plain terms, this means the tablets may not dissolve in the body as intended. When a drug doesn’t meet these specifications, the medication might not be as effective, or it may not release the correct dosage of the active ingredient into the patient’s system.
The FDA has classified this as a “Class II” recall. This classification indicates that while the situation is serious, the product may cause temporary or medically reversible adverse health consequences.
How to Identify Affected Medication
Not all Xanax prescriptions are affected. This recall is limited to a specific lot, and dosage. Patients should check their medication bottles for the following details:
- Manufacturer: Viatris Inc.
- Lot Number: 8177156
- Strength/Type: 3mg extended-release tablets
- Bottle Size: 60 tablets
- Expiration Date: February 28, 2027
According to the California State Board of Pharmacy, these specific pills were distributed nationwide between August 27, 2024, and May 29, 2025.
What Should You Do If Your Medication Is Recalled?
If you have a bottle of Xanax that matches the lot number and expiration date mentioned above, don’t panic, but do take action. Because these medications are used to treat anxiety and panic disorders, stopping them abruptly or taking an ineffective dose can be problematic.
Recommended Steps:
- Verify the Lot Number: Check the side or bottom of your prescription bottle for Lot #8177156.
- Consult Your Healthcare Provider: Contact your doctor or pharmacist immediately to discuss a replacement.
- Do Not Abruptly Stop Treatment: Always speak with a medical professional before changing how you take your medication to avoid potential withdrawal or health complications.
Frequently Asked Questions
What does “dissolution specifications” actually indicate?
Dissolution is the process by which a drug tablet dissolves in the gastrointestinal tract so the medication can be absorbed into the bloodstream. If a pill fails dissolution specifications, it may dissolve too slowly, too quickly, or not at all, which prevents the patient from receiving the prescribed dose.
Is all Xanax being recalled?
No. This is a targeted recall affecting only 3mg extended-release tablets from lot number 8177156 manufactured by Viatris Inc. Other dosages, formats, or lots are not included in this specific alert.
Who is responsible for the recall?
The recall was voluntarily issued by Viatris Inc. and reported by the FDA.
Patients are encouraged to remain vigilant and regularly check for recall alerts to ensure their medications are safe and effective.
Keep reading